Department of Bioengineering, Hanyang University

(
)


  • 상 miRNA


  1. Chuanyu Zhuang, Chunxian Piao, Minji Kang, Jihun Oh, and Minhyung Lee (2023) Hybrid nanoparticles with cell membrane and dexamethasone-conjugated polymer for gene delivery into the lungs as therapy for acute lung injury. Biomater. Sci. 11: 3354-3364.
  2. Chuanyu Zhuang, Minji Kang, and Minhyung Lee (2023) Delivery systems of therapeutic nucleic acids for the treatment of acute lung injury/acute respiratory distress syndrome. J. Control. Release 360: 1-14.
  3. Chunxian Piao1, Chuanyu Zhuang1, Min Kyung Ko, Do Won Hwang*, and Minhyung Lee* (2022) Pulmonary delivery of a recombinant RAGE antagonist peptide derived from high-mobility group box-1 in a bleomycin-induced pulmonary fibrosis animal model. J. Drug Target. 30(7): 792-799. (1Co-first authors, *Co-corresponding authors).
  4. Chunxian Piao, Chuanyu Zhuang, Minji Kang, Jihun Oh, and Minhyung Lee (2022) Pulmonary delivery of curcumin-loaded glycyrrhizic acid nanoparticles for anti-inflammatory therapy. Biomater. Sci. 10(23): 6698-6706.
  5. Chuanyu Zhuang, Chunxian Piao, Myoungjee Choi, Junkyu Ha, and Minhyung Lee (2021) Delviery of miRNA-92a inhibitor using RP1-liked peptide elicits anti-inflammatory effects in an acute lung injury model. J. Biomed. Nanotechnol. 17: 1273-1283.
  6. Chunxian Piao, Chuanyu Zhuang, Myoungjee Choi, Junkyu Ha, and Minhyung Lee (2020) A RAGE-antagonist peptide potentiates polymeric micelle-mediated intracellular delivery of plasmid DNA for acute lung injury gene therapy. Nanoscale. 12(25): 13606-13617.